RFPs
SHARE
SHARE
Resource Downloads
Download RFP
The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or evaluate interventions.
A brief Letter of Intent is due Friday, December 10, 2021. Proposals will be accepted through Friday, March 11, 2022. To learn more about this opportunity, please download the relevant RFP below or reach out to our team at [email protected]
SHARE
Related Content
-
Misophonia - A Giving Smarter Guide
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...Read ReportJR
-
2023 Request for Proposals: Misophonia Research Fund
The Misophonia Research Fund (MRF) and the Milken Institute have partnered for the past four years to advance a world where misophonia is scientifically understood and effective treatments are available to help anyone who lives with this...Read Article -
Consensus Definition of Misophonia A Delphi Study
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience...Read Report
-
Uterine Leiomyosarcoma: A Giving Smarter Guide
This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...Read ReportIM
-
The Global Brain Care Coalition: A Model to Put Brain Science into Action
It takes an average of 17 years for a scientific discovery to travel from the lab to clinical practice. In brain health, that delay has a real cost as the global population ages and more people face conditions such as dementia, stroke, and...Read Report
-
Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment
February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...Read Article -
Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial
The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...Read Article -
Request for Proposals: ALS Breakthrough Research Fund
Tambourine is launching the ALS Breakthrough Research Fund. This new fund will support basic and discover-focused research in amyotrophic lateral sclerosis (ALS).Read Article